Ancora Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,948
| Closed | – | – | 1941 |
|
|
2024
Q2 | $0 | Hold |
4,948
| – | – | ﹤0.01% | 1944 |
|
|
2024
Q1 | $0 | Hold |
4,948
| – | – | ﹤0.01% | 1873 |
|
|
2023
Q4 | $0 | Hold |
4,948
| – | – | ﹤0.01% | 1848 |
|
|
2023
Q3 | $0 | Hold |
4,948
| – | – | ﹤0.01% | 1846 |
|
|
2023
Q2 | $0 | Hold |
4,948
| – | – | ﹤0.01% | 1987 |
|
|
2023
Q1 | $0 | Hold |
4,948
| – | – | ﹤0.01% | 2232 |
|
|
2022
Q4 | $0 | Hold |
4,948
| – | – | ﹤0.01% | 2386 |
|
|
2022
Q3 | $0 | Hold |
4,948
| – | – | ﹤0.01% | 2462 |
|
|
2022
Q2 | $0 | Hold |
4,948
| – | – | ﹤0.01% | 2637 |
|
|
2022
Q1 | $0 | Hold |
4,948
| – | – | ﹤0.01% | 2819 |
|
|
2021
Q4 | $0 | Hold |
4,948
| – | – | ﹤0.01% | 2560 |
|
|
2021
Q3 | $0 | Hold |
4,948
| – | – | ﹤0.01% | 2361 |
|
|
2021
Q2 | $0 | Hold |
4,948
| – | – | ﹤0.01% | 2169 |
|
|
2021
Q1 | $0 | Hold |
4,948
| – | – | ﹤0.01% | 1861 |
|
|
2020
Q4 | $12K | Sell |
4,948
-456,775
| -99% | -$1.11M | ﹤0.01% | 1149 |
|
|
2020
Q3 | $1.46M | Sell |
461,723
-1,231,493
| -73% | -$3.88M | 0.06% | 268 |
|
|
2020
Q2 | $4.93M | Sell |
1,693,216
-83,568
| -5% | -$243K | 0.21% | 116 |
|
|
2020
Q1 | $5.01M | Buy |
1,776,784
+101,823
| +6% | +$287K | 0.23% | 111 |
|
|
2019
Q4 | $5.44M | Buy |
1,674,961
+1,312,437
| +362% | +$4.26M | 0.2% | 132 |
|
|
2019
Q3 | $783K | Buy |
362,524
+646
| +0.2% | +$1.4K | 0.03% | 369 |
|
|
2019
Q2 | $1.14M | Sell |
361,878
-68,426
| -16% | -$215K | 0.05% | 266 |
|
|
2019
Q1 | $1.6M | Sell |
430,304
-42,203
| -9% | -$157K | 0.07% | 247 |
|
|
2018
Q4 | $1.37M | Buy |
472,507
+199,800
| +73% | +$579K | 0.07% | 247 |
|
|
2018
Q3 | $717K | Buy |
+272,707
| New | +$717K | 0.03% | 408 |
|